AstraZeneca holds talks with Bristol Myers Squibb on $400B megadeal: report
The deal could create one of the world's biggest pharmaceutical groups with a combined value of nearly $400 billion.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
